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K e y  M e s s a g e 
In Chinese women who require breast cancer 
surgery, use of a decision aid booklet reduces 
decisional conflict, treatment decision-making 
difficulty, and post-surgery decision regret. Decision 
aids should be available as part of the routine clinical 
service, specifically to support post-consultation 
decision making.
Decision aids for breast cancer surgery:  
a randomised controlled trial
Introduction
Breast cancer management involves medical, surgical, 
and radiotherapeutic treatments. Our previous study 
showed that approximately one in seven of the ~2500 
Chinese women diagnosed with breast cancer each 
year suffer from increased psychological morbidity 
attributable to treatment decision-making (TDM) 
difficulty.1,2 Two-thirds of the women preferred 
shared rather than sole responsibility for TDM, with 
guidance received from doctors.3 However, most 
women were left to decide on treatment alone, and 
many opted to have more extensive surgery than 
necessary, owing to a fear of prolonged treatment 
and associated social stigmatisation.3 The social 
and relationship consequences of this choice are 
often poorly comprehended before treatment and 
thus compound subsequent psychosocial morbidity. 
Information and decision-support strategies are 
needed to optimise women’s breast cancer TDM. 
 Decision aids facilitate decision making by 
emphasising alternatives, probability of risks and 
benefits, and personal values.4 In a systematic review 
of the effect of decision aids in women with breast 
cancer, those who used a decision aid were more 
likely to choose breast-conserving therapy, were 
more knowledgeable about breast cancer, and had 
less decisional conflict and were more satisfied with 
the decision-making process.5 Nonetheless, there is 
no evidence that decision aids directly benefit health 
outcomes such as psychological morbidity. Their 
benefit may be mediated by patient satisfaction with 
the decision process. 
 This study assessed the effect of decision 
aids on the decision-making process, satisfaction 
with TDM, and psychological morbidity in women 
undergoing breast cancer surgery.
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Methods
This randomised controlled trial was conducted 
from December 2009 to November 2011 at Kwong 
Wah Hospital Breast Centre and Tung Wah Hospital 
Breast Centre. Ethical approval was obtained. 
Cantonese/Mandarin-speaking Chinese women 
with early-stage breast cancer who had no other 
cancer history, were fit for surgery, and consented to 
be interviewed were invited to participate. Patients 
were excluded if they were to receive chemotherapy 
as a neo-adjuvant therapy, came for a second 
opinion, had metastasis or recurrence of breast 
cancer, or were cognitively impaired or physically 
unfit to complete the interview. 
 Women were block randomised by week 
to either an intervention (decision aid booklet) 
or control (standard-information booklet) arm. 
Procedures and wordings were identical. The 
corresponding booklet was provided prior to 
making a decision by telephone about treatment. 
The decision aid booklet comprised information 
about (1) the main differences between the available 
treatment options and their associated probable 
outcome, (2) benefits and costs of the available 
treatments, (3) methods for clarifying patients’ 
values, and (4) structured guidance in reaching 
a decision. The standard-information booklet 
contained information on diagnosis, treatment, and 
management of breast cancer in general terms and 
was not designed to help make a specific, personal 
treatment decision. 
 Women were asked to complete questionnaires 
immediately (baseline: time 1) and within 7 days 
(time 2) of consultation, and at 4 weeks (time 3), 
4 months (time 4), and 10 months (time 5) post-
surgery. Face-to-face interviews were conducted at 
HEALTH AND HEALTH SERVICES RESEARCH FUND
Hong Kong Med J  ⎥  Volume 20 Number 6 (Supplement 7)  ⎥  December 2014  ⎥  www.hkmj.org
#  Decision aids for breast cancer surgery  # 
25Hong Kong Med J  ⎥  Volume 20 Number 6 (Supplement 7)  ⎥  December 2014  ⎥  www.hkmj.org
baseline and follow-up assessments. 
 Outcome measures included satisfaction with 
the decision process (scores of TDM difficulty and 
decisional conflict), psychological morbidity (scores 
of Chinese Health Questionnaire and Hospital 
Anxiety and Depression Scale [HADS]), satisfaction 
with the treatment decision (scores of decision 
regret), and knowledge of breast cancer. 
 The two groups were compared using linear 
mixed effects (LME) models to control the random 
effects of hospital sites and surgeons. Covariates 
correlated with outcome measures were also included 
in the models to adjust for confounders. Intention-
to-treat analysis was also used. For repeated 
measures (decision regret, psychological distress, 
and realistic outcome expectation), mean differences 
within and between groups were analysed using 
LME models, with random subject effects estimated 
for the intercept, slope for time, time-squared, and 
time-cubed. The quadratic and cubic effects of time 
were included to account for non-linear change over 
time. The LEM model was adjusted for relevant 
demographic and clinical variables, and decision-
making factors. To assess whether the booklet 
significantly influenced psychological morbidity, the 
mediating effect of patient satisfaction with TDM 
and use of the booklet on psychological morbidity 
was tested.
Results
A total of 276 women were randomised to the 
intervention (n=138) or control (n=138) group (Fig 
1); 225 (81.5%) women (113 in intervention and 
112 in control groups) were offered more than one 
treatment option (Table 1). Compared with controls, 
decision aids were associated with lower scores for 
TDM difficulty (β=1.8, P=0.016), decisional conflict 
(β=5.8, P=0.004), and decision regret (β=4.55, P<0.05) 
[Table 2]. Nonetheless, the two groups did not differ 
significantly in terms of decision regret at 4 weeks, 
FIG.  The CONSORT diagram
Assessed for eligibility (n=540)
Block randomisation (by week of 
attendance) (n=276)
Pre-intervention assessment completed (n=276)
Allocated to intervention (n=138)
1st post-intervention assessment completed (n=138)
2nd post-intervention assessment completed 
(n=118), lost to follow-up (n=15), and refused (n=5)
3rd post-intervention assessment completed (n=110), 
lost to follow-up (n=13), and refused (n=15)
4th post-intervention assessment completed (n=107), 
lost to follow-up (n=8), refused (n=21), and 
deceased (n=2)
Excluded from analysis (n=25)
Analysed at baseline and 1st, 2nd, 3rd, and 4th post-
intervention assessment (n=113, 113, 101, 91, 88, 
respectively) 
1st post-intervention assessment completed (n=138)
2nd post-intervention assessment completed 
(n=119), lost to follow-up (n=15), and refused (n=4)
3rd post-intervention assessment completed (n=106), 
lost to follow-up (n=17), and refused (n=15)
4th post-intervention assessment completed (n=107), 
lost to follow-up (n=9), refused (n=21), and 
deceased (n=1)
Excluded from analysis (n=26) 
Analysed at baseline and 1st, 2nd, 3rd, and 4th post-
intervention assessment (n=112, 112, 97, 88, 90, 
respectively)
Allocated to Control (n=138)
Excluded (n=264)
•  Not meeting inclusion criteria (n=217)
•  Declined to participate (n=30)
•  Failed to trace the patients (n=17)
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realistic outcome expectation, knowledge of breast 
cancer, or scores of Chinese Health Questionnaire, 
HADS-Anxiety and HADS-Depression. 
Discussion
Decision aids decreased TDM difficulty, decisional 
conflict, and decision regret, without increasing 
anxiety. Decision aids could be an adjunct to post-
consultation support in TDM. The effect of decision 
aids on psychological morbidity was not mediated 
by patient satisfaction with the decision process. 
Psychological distress was associated with TDM 
difficulty, decision regret, and lack of treatment 
recommendation from the surgeon. Decision aids 
minimised TDM difficulty. This highlights the 
importance of reducing the level of TDM difficulty 
for women considering breast cancer surgery. Future 
study is needed to identify the optimal strategy 
TABLE 1.  Patient demographics*
Variable Decision aids (n=138) Controls (n=138) P value
Age (years) 56.8±10.8 54.6±10.1 >0.05
Marital status >0.05
Married 85 (61.6) 87 (63)
Single 21 (15.2) 19 (13.8)
Divorced 12 (8.7) 12 (8.7)
Widowed 20 (14.5) 20 (14.5)
Education level >0.05
No formal education 8 (5.8) 11 (8.0)
Primary 44 (31.9) 40 (29.0)
Secondary 71 (51.4) 73 (52.9)
Tertiary 15 (10.9) 14 (10.1)
Occupation >0.05
Employed 51 (36.9) 63 (45.6)
Retired 37 (26.8) 27 (19.6)
Housewife 40 (29) 30 (21.7)
Unemployed 10 (7.25) 18 (13.0)
Monthly household income (HK$) >0.05
≤10 000 55 (42) 56 (43.8)
10 001-20 000 43 (32.8) 36 (28.1)
20 001-30 000 18 (13.7) 20 (15.6)
30 001-40 000 8 (6.1) 9 (7.0)
>40 000 7 (5.3) 7 (5.5)
Family history of breast cancer 14 (10.1) 13 (9.4) >0.05
More than one treatment choice 113 (83.7) 112 (83.0) >0.05
Stage of breast cancer >0.05
0 31 (37.8) 21 (28.8)
I/II 42 (51.3) 47 64.4)
III 9 (11) 5 (6.8)
Active chemotherapy
At 1 month 21 (18.1) 19 (22) >0.05
At 4 months 29 (28.2) 26 (25) >0.05
At 10 months 0 (0) 0 (0) >0.05
Active radiotherapy
At 1 month 9 (8.6) 5 (4.8) >0.05
At 4 months 9 (8.6) 4 (4.8) >0.05
At 10 months 2 (2) 1 (1) >0.05
Active hormonal therapy
At 4 months 31 (30.1) 33 (31.7) >0.05
At 10 months 65 (63.7) 64 (62.7) >0.05
* Data are presented as mean±SD or No. (%) of patients
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TABLE 2.  Comparison of outcomes
Variable Decision 
aid (n=113) 
Mean±SD
Controls 
(n=112) 
Mean±SD
Adjusted β±SE (95% CI) 
[decision aid as 
reference]
P value (95% CI)
Treatment decision-making difficulty 17.5±6.3 19.1±6.4 1.8±0.7 (0.34-3.24) 0.016 (0.34-3.24)
Decisional conflict 15.8±15.5 19.9±16.3 5.8±1.9 (1.85-9.71) 0.004 (1.85-9.71)
Knowledge of breast cancer 6.1±2.1 5.9±2.1 -0.17±0.2 (-0.65-0.31) >0.05 (-0.65-0.31)
Chinese Health Questionnaire 
4 weeks 7.8±4.8 8.3±5.8 0.5±0.6 (-0.71-1.70) >0.05 (-0.71-1.70)
4 months 7.6±5.3 7.3±5.6 0.21±0.69 (-1.17-1.57) >0.05
10 months 6.7±4.9 7.5±5.6 1.4±0.7 (-0.07-2.86) >0.05
Hospital Anxiety and Depression Scale (HADS)-Anxiety
4 weeks 2.5±3.2 2,6±3.3 -0.1±0.4 (-0.94-0.67) >0.05 (-0.94-0.67)
4 months 2.2±3.2 2.1±3.1 -0.08±0.38 (-0.85-0.68) >0.05
10 months 2.7±3.5 2.8±3.6 0.28±0.47 (-0.65-1.22) >0.05
HADS-Depression
4 weeks 2.3±2.7 2.3±2.7 0.1±0.3 (-0.58-0.61) >0.05 (-0.58-0.61)
4 months 2.1±3.3 1.9±2.4 0.07±0.32 (-0.56-0.71) >0.05
10 months 1.4±1.9 2.5±3.4 1.38±0.41 (0.58-2.19) 0.001 
Decision regret
4 weeks 21.4±17.2 23.1±18.3 1.6±2.4 (-3.19-6.47) >0.05 (-3.19-6.47)
4 months 18.8±15.8 24.4±18.9 5.9±2.5 (0.95-10.84) 0.02 
10 months 20.1±14.5 24.6±18.8 6.1±2.4 (1.28-10.94) 0.014 
Realistic outcome expectation
4 weeks -0.01±0.64 -0.11±0.56 -0.04±0.08 (-0.20-0.11) >0.05 (-0.20-0.11)
4 months -0.19±0.64 -0.20±0.56 0.05±0.09 (-0.13-0.24) >0.05 (-0.13-0.24)
10 months -0.28±0.56 -0.22±0.57 0.15±0.09 (-0.21-0.33) >0.05
Surgical decision
No. (%) of patients having breast-conserving therapy 
(BCT) as an option
Out of 73 Out of 86 >0.05
BCT 29 (43) 41 (51)
Modified radical mastectomy (MRM) 31 (46) 32 (39)
MRM plus reconstruction 7 (10) 7 (10)
No. (%) of patients not having BCT as an option Out of 40 Out of 26 >0.05
BCT 3 (7.9) 1 (4.3)
MRM 30 (78.9) 14 (60.9)
MRM plus reconstruction 5 (13.2) 8  (34.8)
to integrate decision aids into routine clinical 
practice. 
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